|
Fusion gene ID: 8961 |
FusionGeneSummary for CTU2_MLYCD |
Fusion gene summary |
Fusion gene information | Fusion gene name: CTU2_MLYCD | Fusion gene ID: 8961 | Hgene | Tgene | Gene symbol | CTU2 | MLYCD | Gene ID | 348180 | 23417 |
Gene name | cytosolic thiouridylase subunit 2 | malonyl-CoA decarboxylase | |
Synonyms | C16orf84|NCS2|UPF0432 | MCD | |
Cytomap | 16q24.3 | 16q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | cytoplasmic tRNA 2-thiolation protein 2cytosolic thiouridylase subunit 2 homolog | malonyl-CoA decarboxylase, mitochondrialmalonyl coenzyme A decarboxylase | |
Modification date | 20180523 | 20180522 | |
UniProtAcc | Q2VPK5 | O95822 | |
Ensembl transtripts involved in fusion gene | ENST00000453996, ENST00000378384, ENST00000312060, ENST00000567949, | ENST00000262430, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 2 X 2 X 2=8 |
# samples | 3 | 2 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: CTU2 [Title/Abstract] AND MLYCD [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | MLYCD | GO:0006085 | acetyl-CoA biosynthetic process | 9869665|10417274|10455107 |
Tgene | MLYCD | GO:0006633 | fatty acid biosynthetic process | 15003260 |
Tgene | MLYCD | GO:2001294 | malonyl-CoA catabolic process | 10417274|10455107|15003260 |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-BH-A1FD-01A | CTU2 | chr16 | 88779313 | + | MLYCD | chr16 | 83945823 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000453996 | ENST00000262430 | CTU2 | chr16 | 88779313 | + | MLYCD | chr16 | 83945823 | + |
Frame-shift | ENST00000378384 | ENST00000262430 | CTU2 | chr16 | 88779313 | + | MLYCD | chr16 | 83945823 | + |
Frame-shift | ENST00000312060 | ENST00000262430 | CTU2 | chr16 | 88779313 | + | MLYCD | chr16 | 83945823 | + |
Frame-shift | ENST00000567949 | ENST00000262430 | CTU2 | chr16 | 88779313 | + | MLYCD | chr16 | 83945823 | + |
Top |
FusionProtFeatures for CTU2_MLYCD |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
CTU2 | MLYCD |
Plays a central role in 2-thiolation of mcm(5)S(2)U attRNA wobble positions of tRNA(Lys), tRNA(Glu) and tRNA(Gln). Mayact by forming a heterodimer with CTU1/ATPBD3 that ligates sulfurfrom thiocarboxylated URM1 onto the uridine of tRNAs at wobbleposition. {ECO:0000255|HAMAP-Rule:MF_03054,ECO:0000269|PubMed:19017811}. | Catalyzes the conversion of malonyl-CoA to acetyl-CoA.In the fatty acid biosynthesis MCD selectively removes malonyl-CoAand thus assures that methyl-malonyl-CoA is the only chainelongating substrate for fatty acid synthase and that fatty acidswith multiple methyl side chains are produced. In peroxisomes itmay be involved in degrading intraperoxisomal malonyl-CoA, whichis generated by the peroxisomal beta-oxidation of odd chain-lengthdicarboxylic fatty acids. Plays a role in the metabolic balancebetween glucose and lipid oxidation in muscle independent ofalterations in insulin signaling. May play a role in controllingthe extent of ischemic injury by promoting glucose oxidation.{ECO:0000269|PubMed:10455107, ECO:0000269|PubMed:15003260,ECO:0000269|PubMed:18314420, ECO:0000269|PubMed:23482565}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CTU2_MLYCD |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CTU2_MLYCD |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
CTU2 | CTU1, MMS19, FAM96B, CIAO1, KLHL20, WISP2, UROS, KCTD17, RRAGA, NFKBIA, FAS, FAM219A, VAPB, CCNDBP1, LBHD1, TINAG, MYCL, THUMPD3, ZMAT5, CCDC120, PFDN4, POLM, RAB8B, RGS20, FAM174A, CEP72, APEX2, FAM19A3, SLC5A5, PROSER2 | MLYCD | PEX5, FYCO1, COQ6, ADCK1, PCDHGA5, PCDHA9, PCDHA10, PCDHA12, PCDHA3, SNX9 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CTU2_MLYCD |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CTU2_MLYCD |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |